Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomicsStephan M. Tirier, Karsten Rippe, Nicola Casiraghi et al.|Nature Communications|2021Cited by 141
Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment OutcomeSimon Steiger, Marc S. Raab, Raphael Lutz et al.|Blood|2022Cited by 4
P-060: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single cell transcriptomicsKarsten Rippe, Marc S. Raab, Stephan M. Tirier et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 0